BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 20558369)

  • 1. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased rate of major malformations in offspring exposed to valproate during pregnancy.
    Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB;
    Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
    Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
    BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring.
    Artama M; Auvinen A; Raudaskoski T; Isojärvi I; Isojärvi J
    Neurology; 2005 Jun; 64(11):1874-8. PubMed ID: 15955936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptic drug regimens and major congenital abnormalities in the offspring.
    Samrén EB; van Duijn CM; Christiaens GC; Hofman A; Lindhout D
    Ann Neurol; 1999 Nov; 46(5):739-46. PubMed ID: 10553991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort.
    Omtzigt JG; Los FJ; Grobbee DE; Pijpers L; Jahoda MG; Brandenburg H; Stewart PA; Gaillard HL; Sachs ES; Wladimiroff JW
    Neurology; 1992 Apr; 42(4 Suppl 5):119-25. PubMed ID: 1574165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital structural anomalies in offspring of women with epilepsy--a population-based cohort study in Finland.
    Artama M; Ritvanen A; Gissler M; Isojärvi J; Auvinen A
    Int J Epidemiol; 2006 Apr; 35(2):280-7. PubMed ID: 16280367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].
    Bonnot O; Vollset SE; Godet PF; d'Amato T; Dalery J; Robert E
    Encephale; 2003; 29(6):553-9. PubMed ID: 15029090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
    Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations?
    Dolk H; Jentink J; Loane M; Morris J; de Jong-van den Berg LT;
    Neurology; 2008 Sep; 71(10):714-22. PubMed ID: 18650491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic therapy and teratogenicity in Turkey.
    Eşkazan E; Aslan S
    Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):261-4. PubMed ID: 1526687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta2-agonists use during pregnancy and the risk of congenital malformations.
    Eltonsy S; Forget A; Blais L
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative safety of antiepileptic drugs during pregnancy.
    Hernández-Díaz S; Smith CR; Shen A; Mittendorf R; Hauser WA; Yerby M; Holmes LB; ;
    Neurology; 2012 May; 78(21):1692-9. PubMed ID: 22551726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of anticonvulsive drugs during pregnancy and the risk of malformations in the newborn: a meta-analysis].
    Gutiérrez-Alvarez AM
    Rev Neurol; 2003 Dec 1-15; 37(11):1022-8. PubMed ID: 14669141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of metoclopramide use in the first trimester of pregnancy.
    Matok I; Gorodischer R; Koren G; Sheiner E; Wiznitzer A; Levy A
    N Engl J Med; 2009 Jun; 360(24):2528-35. PubMed ID: 19516033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.